Pulmonary artery denervation in residual pulmonary hypertension

Summary

Effective treatment of pulmonary hypertension remains one of the challenges of the 21st century and, while we are aware that patients with this condition have an elevated sympathetic activity, what are our treatment options? Can the Symplicity denervation system be seen as one of these as an effective clinical procedure for patients with residual pulmonary hypertension after pulmonary thromboembolism and surgical thrombendarterectomy?

Join B. Rudenko from Russia as he speaks about this promising first-in-human-study.